Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 8:03 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2377–2400 of 2,430 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Learning Disorders Clear all

Conditions: Obesity
Interventions: Adapted Dietary Guidelines, Adapted Physical Activity Guidelines; Behavioral
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 35 Years to 64 Years
Enrollment: 129 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Diabetes
Interventions: Diabetes Medication Choice Decision Aid, Statin Choice Decision Aid, Usual care for lipid therapy medication, Usual care for antihyperglycemic medication; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 5
States / cities: Albert Lea, Minnesota • Austin, Minnesota • Kasson, Minnesota + 1 more

Conditions: Sickle Cell Disease, Cognitive Impairment
Interventions: Cogmed; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 8 Years to 16 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Anxiety Disorders
Interventions: Project EMPOWER, Being Brave Parent Education, Sharing Feelings; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Spinal Cord Injury
Interventions: transcranial direct current stimulation (tDCS) + FTP, transcranial pulsed current stimulation (tPCS) + FTP, transcranial random noise stimulation (tRNS) + FTP, sham transcranial electrical stimulation (tES) + FTP; Other
Lead sponsor: Shepherd Center, Atlanta GA; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Central Line Associated Blood Stream Infections (CLABSI)
Interventions: Infection Preventionist Led Best Practices Reminders; Behavioral
Lead sponsor: Swedish Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 17,800 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 19
States / cities: Anchorage, Alaska • Apple Valley, California • Burbank, California + 15 more

Conditions: Chronic Spontaneous Urticaria
Interventions: Ritlecitinib 50 mg, Ritlecitinib 100 mg, Placebo - 50 mg, Placebo - 100 mg; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 19
States / cities: Phoenix, Arizona • Little Rock, Arkansas • Bakersfield, California + 16 more

Conditions: Type 2 Diabetes
Interventions: Continuous Glucose Monitoring Academy, Standard Education; Behavioral
Lead sponsor: Children's Hospital Los Angeles; Other
Eligibility: 8 Years to 21 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: PTSD, Depression, Opioid Use Disorder
Interventions: Modeling to Learn (MTL), Usual quality improvement (QI); Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 720 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Multiple Myeloma
Interventions: Elranatamab, Standard of care; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Weeks and older
Enrollment: 514 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: Autism Spectrum Disorder, Autism
Interventions: EarliPoint Diagnosis, Clinically Certain Expert Clinician Diagnosis (CC-ECD); Device · Behavioral
Lead sponsor: EarliTec Diagnostics, Inc; Industry
Eligibility: 31 Months to 84 Months
Enrollment: 929 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 9
States / cities: Phoenix, Arizona • Altanta, Georgia • Iowa City, Iowa + 6 more

Conditions: Chronic Kidney Disease (CKD)
Interventions: CKD Registry, ATSM + Health Coach, Usual care; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 75 Years
Enrollment: 375 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2020
U.S. locations: 2
States / cities: San Francisco, California

Conditions: Schizophrenia
Interventions: Dextroamphetamine, Placebo; Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years to 55 Years
Enrollment: 82 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: San Diego, California

Conditions: Movement Disorders, Heathly Subjects
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 18 Years to 50 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Migraine
Interventions: Not listed
Lead sponsor: Theranica; Industry
Eligibility: 8 Years and older
Enrollment: 53,065 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Bridgewater, New Jersey

Conditions: Diabetes Mellitus Type 2, Pre-diabetes
Interventions: Iowa Produce Prescription Program (I-PPP), Produce Your Path Behavioral Nutrition Intervention (PYP); Other · Behavioral
Lead sponsor: Iowa State University; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Ames, Iowa

Conditions: Dyslexia, Acquired, Brain Injuries, Cerebrovascular Accident
Interventions: Cognitive Therapy to Improve Reading; Behavioral
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 18 Years and older
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2007
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Atrial Fibrillation, Atrial Flutter
Interventions: Decision Support, Educational Intervention Only; Behavioral
Lead sponsor: University of Cincinnati; Other
Eligibility: Not listed
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Diabetes Mellitus, Type 2
Interventions: Insulin Education Class; Other
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years and older
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Acute Lymphoblastic Leukemia, Central Nervous System Tumors, Lymphoma
Interventions: Annual Intervention Group, Quarterly Monitoring of IEP; Behavioral
Lead sponsor: University of Miami; Other
Eligibility: 6 Years to 12 Years
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2010
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Obesity, Overweight and/or Obesity, Overweight, Treatment Of Obesity
Interventions: Semaglutide, Berobenatide, Tirzepatide; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 660 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 24
States / cities: Birmingham, Alabama • Canoga Park, California • Los Angeles, California + 20 more

Conditions: Migraine
Interventions: Brain Education and WELLness with Migraine Group A, Brain Education and WELLness with Migraine Group B; Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 286 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 3
States / cities: Cambridge, Massachusetts • Winston-Salem, North Carolina • Cincinnati, Ohio

Conditions: Pulmonary Fibrosis
Interventions: Not listed
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Attention Deficit Hyperactivity Disorder, Reading Disabilities
Interventions: Methylphenidate, Intensive reading instruction, Parent Training, Mixed Salt Amphetamine, Atomoxetine, Guanfacine; Drug · Behavioral
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 7 Years to 12 Years
Enrollment: 222 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 2
States / cities: Cincinnati, Ohio • Houston, Texas

Search by objective public record fields.

Steps Ahead, Adapting Physical Activity Guidelines for the Lower Mississippi Delta Population

Impact of Decision Aids to Enhance Shared Decision Making for Diabetes

Cognitive Rehabilitation in Sickle Cell Disease

Online Parent Education for Child Anxiety

Influence of Transcranial Electrical Stimulation on Arm and Hand Function After Cervical Spinal Cord Injury

Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction

A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.

Type 2 Continuous Glucose Monitoring Academy

Participatory System Dynamics vs Usual Quality Improvement: Staff Use of Simulation as an Effective, Scalable and Affordable Way to Improve Timely Mental Health Care?

A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma

Dynamic Quantification of Social-Visual Engagement in Autism Spectrum Disorder (ASD)

Kidney Awareness Registry and Education

Pharmacologically-augmented Cognitive Therapies (PACTs) for Schizophrenia.

Changes in the Posterior Parietal Cortex - Primary Motor Cortex Pathway Induced by Motor Training

Machine Learning Assessment of Next-Day Migraine Likelihood

Iowa Produce Prescription Program

Therapy for Reading Problems in Adults After Brain Injury

Impact of an Atrial Fibrillation Decision Support Tool (AFDST) on Thromboprophylaxis for Atrial Fibrillation

Do Group Insulin Education Visits Reduce Barriers to Insulin Initiation?

Assessing the Effectiveness of Individual Education Plans for Childhood Cancer Survivors

A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity

BE WELL With Migraine: Brain Education and WELLness With Migraine

Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary Fibrosis

Interventions for Children With Attention and Reading Disorders